Depression Research and Treatment

Depression Research and Treatment / 2021 / Article

Research Article | Open Access

Volume 2021 |Article ID 6652133 |

Wadha K. Almeshari, Alanoud K. Alsubaie, Reham I. Alanazi, Yara A. Almalki, Nazish Masud, Sami H. Mahmoud, "Depressive and Anxiety Symptom Assessment in Adults with Polycystic Ovarian Syndrome", Depression Research and Treatment, vol. 2021, Article ID 6652133, 8 pages, 2021.

Depressive and Anxiety Symptom Assessment in Adults with Polycystic Ovarian Syndrome

Academic Editor: Janusz K. Rybakowski
Received02 Nov 2020
Revised07 Mar 2021
Accepted29 Mar 2021
Published19 Apr 2021


Background. Polycystic ovarian syndrome (PCOS) is an endocrinopathic disorder commonly affecting women in the reproductive age. These women have a possibility of developing depression and anxiety due to biochemical changes, concerns regarding physical appearance, and social pressure from infertility. Thus, the connection between PCOS, anxiety, and depression has a possible impact on patients’ quality of life. This study is aimed at assessing depression and anxiety symptoms among PCOS patients and their association with different socioeconomic aspects. Methods. A cross-sectional study was conducted to assess depression and anxiety symptoms on 250 PCOS patients which were selected through consecutive sampling technique. Arabic versions of the HAM-A and HAM-D questionnaires were used alongside a demographic sheet to determine the socioeconomic and fertility status. Results. Prevalence of anxiety symptoms was reported among 100 (40%) of women and was found to be significantly higher in single women with a prevalence of 59 (48%) (, value <0.01). Also, lower-income status and unemployment were associated with a significantly higher prevalence of anxiety 18 (67%) (, value =0.03) and 71 (45%) (, value =0.03) women, respectively. Depressive symptoms were reported among 122 (49%) participants. Conclusion. Single marital status, low income, and unemployment were predictors of anxiety. Tension was noted to be the most common anxiety symptom among participants while depressed mood and psychological anxiety were the most reported depressive symptoms. It is important to note the link between anxiety, PCOS, and depression when deciding treatment plans for affected women.

1. Introduction

Polycystic ovarian syndrome (PCOS) is an endocrinopathic disorder commonly affecting women in the reproductive age group [1]. It is the most common endocrine disorder; its prevalence ranges from 2.2% to 26.7% worldwide [2]. In Saudi Arabia, the prevalence of PCOS has not been yet identified; however, 82% of women presenting with hirsutism are found to have PCOS [3]. Its diagnostic criteria include chronic oligo or anovulation, defined as irregular or none occurring menstrual cycles, presence of ovarian cysts on ultrasound examination, and high levels of androgen hormones [4]. Increasing androgen levels causes alopecia, acne, and hirsutism, which can affect physical, social, and emotional wellbeing of women [5].

Many studies have shown the association of depression and anxiety with PCOS. One which was conducted in China showed the prevalence of depression and anxiety among PCOS patients to be 27.5% and 13.3%, respectively [6]. Moreover, a study conducted on adolescents with PCOS in Turkey found the prevalence of depression to be significantly higher [7]. The psychological effect of PCOS is found to be due to its physical manifestations and symptoms, such as obesity, hirsutism, and acne, which lead to low self-esteem and dissatisfaction regarding the physical appearance [8]. The biochemical effect is due to androgen excess and abdominal obesity, leading to dyslipidemia in some cases and other metabolic impairments, but the direct mechanism is not determined yet [8, 9]. PCOS patients experience anovulation and menstrual irregularity leading to fertility difficulties after marriage, which is one of the major reasons for social and family pressures leading to depression and anxiety [10].

The current study is aimed at evaluating the prevalence of depressive and anxiety symptoms among women with PCOS within the child bearing age group. Furthermore, its goal was to understand the association between different socioeconomic aspects such as marital status, number of children, infertility, and income with the presence and severity of different depressive and anxiety symptoms, due to such factors being highly impactful on a person’s psychological well-being. Moreover, the matters of marriage and childbearing are of a higher concern for affected women since they are considered to be emotional, instinctive, and social needs [11]. Assessment of the abovementioned aims would lead to more future awareness regarding the magnitude of PCOS psychological effects and the patients’ concerns that needs to be addressed at the time of diagnosis, which in turn will modify treatment plans to include psychological screening, counseling, and psychiatric help as part of PCOS management [12].

2. Subjects and Methods

Ethical approval of this study was obtained from the IRB/0355/19 on 12th of March 2019, and written consent was obtained from the participants to assure their confidentiality.

2.1. Study Design and Settings

A cross-sectional study was conducted on women with PCOS to assess depression and anxiety symptoms. This study was conducted at gynecology clinics at Khashm Al-An primary health care center in King Abdulaziz Medical City in Riyadh, a governmental center for eligible and dependent people who had first-degree relatives working in Saudi Arabian National Guard or National Guard Health Affairs facilities.

2.2. Participants

To identify the potential participants, gynecology clinics were visited on weekly basis to check the list of appointments and determine all PCOS patients. While waiting for their appointments, women with PCOS were met and given the surveys by coinvestigators after informed written consent. The participants who were included in this study had to be in the 18 to 50 years old age group, with no chronic conditions other than PCOS. Pregnant women, those with diagnosed psychiatric disorders, acute illnesses, or who are being administered any psychiatric medications were excluded. Also, participants who experienced a recent unpleasant event, for example, death or sickness of a close family member, financial issues, or job loss, were excluded, due to the fact that such events are considered life stressors causing distress, and thus, they might have led to an overestimation of depressive or anxiety symptoms. Sample size calculation was based on a 6.2% margin of error, 95% confidence level, and 50% estimated prevalence due to absence of studies that reported the prevalence of depressive and anxiety symptoms in PCOS patients; thus, the minimum required sample size was estimated to be 247 subjects.

2.3. Data Sources

Data was collected using prevalidated self-administered Arabic version of HAM-A and HAM-D questionnaires [13, 14]. A demographic sheet was given to the participants to evaluate the sociodemographic factors. Hamilton Anxiety Rating Scale (HAM-A) in Arabic version was used to assess the presence of anxiety [13, 15, 16]. It is a fourteen-item questionnaire assessing the intensity of symptoms commonly found in anxiety, such as fears, cardiovascular manifestations relating to anxiousness, sensory somatic complaints, and insomnia. All the items were ranked on five levels Likert scale (0-4). Zero meaning that there were no symptoms experienced, and four reflecting very intense symptoms. The minimum score was zero, and maximum was 56. A score of 14 or more is suggested as the threshold for anxiety symptoms [15]. Hamilton Depression Rating Scale (HAM-D) in Arabic version includes seventeen questions assessing different domains of depression including somatic manifestation, suicidal ideation, agitation, and guilt feelings [14, 15, 17]. First seven items had five levels (0-4), the 8th had four levels (0-3), while the rest had three levels (0-2). The score ranged from 0 to 49. A score of 10 is suggested as the threshold for depressive symptoms [15].

2.4. Statistical Analysis

Statistical analysis was performed using Statistical Package for the Social Sciences version 22 (SPSS Inc., Chicago, IL). Reliability testing for both questionnaires was done, HAM-A (14-item) Arabic version had a Cronbach alpha of 0.88, whereas Cronbach alpha for HAM-D (17-item) Arabic version was 0.78, and the Cronbach alpha for the total 31 items was 0.9. Followed by descriptive statics reporting frequencies and percentages for categorical variables such as marital status and monthly income, while mean and standard deviation for continuous variables such as age and duration of infertility. For both HAM-A and HAM-D questionnaires, a total score was computed adding up all the frequencies for the individual items. For HAM-A questionnaire (14 items), the categories were made and scores of <17 for mild anxiety, 18-24 for moderate anxiety, and 25-for severe anxiety. HAM-D questionnaire (17 items) had a score range of 0-49, with a cut-off point of 0-7 for normal symptoms, 8-13 for mild depression, 14-18 for moderate depression, 19-22 for severe, and >23 for very severe depression. Inferential statistics using Chi-square was used to assess the association of sociodemographic characteristics with anxiety and depression. Chi-square test was also used to assess intergroup significance for marital status and anxiety symptoms.

3. Results

3.1. Demographic Characteristics

A total of 250 patients were recruited for this study with a mean age of years and 124 (49%) of them being single. Unemployed participants were 162 (65%), and 27 (11%) have a monthly income lower than 3000 Saudi Riyal and 71 (28%) with a monthly income of 18,000 Saudi Riyal and more. A median of 36 (24-132) months was the duration since PCOS diagnosis for the patients. Among the married participants (), 54 (51%) had conception delay reported post-PCOS diagnosis. (Table 1).




Marital statusSingle12449%

Children ()No4418%

Educational levelNo education10%
High school5121%
Higher degree115%

Occupational statusNonemployed16265%

Monthly income<3000 SR2711%
3000 to 7000 SR4618%
8000 to 12000 SR7128%
13000 to 17000 SR3514%
18000 SR and more7128%

Duration since diagnosis in monthsMedian (Q1-Q3)36 (24-132)

Px taking PCOS treatmentYes13158%

PCOS treatment duration in monthsMedian (Q1-Q3)12 (6-96)

Presence of conception delay ()5451%

Duration of conception delay in years

Pregnancy after delayed conception ()2443%

The use of assisting techniques for conception ()1882%

3.2. Assessment of Anxiety and Depressive Symptoms

The depression and anxiety symptoms among PCOS patients were assessed with the Hamilton Depression Rating Scale (HAM-D) and Hamilton Anxiety Rating Scale (HAM-A). A total anxiety score of was noted, and out of 250 participants, 184 (77%) had mild anxiety score, and 14 (6%) had severe anxiety. Tension was seen to be the most prominent anxiety symptoms 183 (73%), whereas somatic (muscular) pain was the lowest 88 (35%). Anxiety symptoms were noted in 100 responses (40%) while 150 (60%) had no anxiety symptoms. A total depression score of was noted in the study, and within 250 responses, 97 (39%) had a normal score, whereas 11 (4%) had very severe depression. Depressed mood was reported in 154 participants, and psychological anxiety was reported in 156. They were the two most noted depressive symptoms with a percentage of (62%), whereas suicidal ideation was the lowest 26 (10%). Depressive symptoms were reported in 122 participants as opposed to 128 (51%) who had none (Table 2 and Figure 1).

VariablesCategories (%)

Total score anxiety
Median (Q1-Q3)

10 (6-29)

Total score depression
Median (Q1-Q3)

9 (6-22)

Anxiety ()Absent150 (60%)
Present100 (40%)

Anxiety categoriesMild anxiety ()184 (77%)
Moderate anxiety (score 18-24)42 (18%)
Severe anxiety (score 25-30)14 (6%)

Depression ()Absent128 (51%)
Present122 (49%)

Depression categoriesNormal (score 0-7)97 (39%)
Mild depression (score 8-13)75 (30%)
Moderate depression (score 14-18)48 (19%)
Severe depression (score 19-22)19 (8%)
Very severe depression ()11 (4%)

3.3. Association of Demographic Characteristics with Anxiety and Depressive Symptoms

Among the demographic variables, marital status, monthly income, and occupational status were statically significantly associated with the presence of anxiety symptoms. Single women were more likely to have anxiety symptoms with 59 (48%) (, value <0.01). Furthermore, lower income was associated with a higher prevalence of anxiety symptoms 18 (67%) (, value =0.03); additionally, nonemployed women were more likely to have anxiety symptoms compared to employed women 71 (45%) vs. 29 (31%) (, value =0.03). For depressive symptoms, none of the sociodemographic indicators showed significant results on cross-tabulation. However, those who experienced conception delay were more depressed than others who did not experience any, showing as a 30 (56%) vs. 19 (37%) with a value of 0.06, demonstrating that the conception delay is borderline significant (Table 3).

Anxiety valueDepression value

Marital statusSingle6552%5948%0.015746%6754%0.10

Conception delayNo3569%1631%0.173263%1937%0.06


Monthly income<3000 SR933%1867%0.031141%1659%0.66
3000 to 7000 SR2657%2044%2146%2554%
8000 to12000 SR4665%2535%3854%3347%
13000 to 17000 SR2469%1131%1954%1646%
18000 SR and more4563%2637%3955%3245%

Occupational statusNon-employed8655%7145%0.037447%8353%0.08

PCOS drugNo7860%5341%0.536953%6247%0.31

Educational statusHigh school or less2953%2647%0.222953%2647%0.77
Bachelor or higher11962%7338%9751%9550%

The Chi-square statistic is significant at the 0.05 level.
3.4. Association of Anxiety Symptoms with Marital Status

Out of the 14 anxiety symptoms in HAM-A, six symptoms were found to be significantly associated with single participants. Anxious mood was one of the symptoms found to be significant among single participants 93 (55%) (, value =0.013); additionally, somatic muscular symptoms 54 (61%) (, value =0.007), gastrointestinal symptoms (, value =0.023), fears in 58 (57%) (, value =0.042), depressed mood in 83 (58%) (, value =0.003), and respiratory symptoms in 63 (57%) (, value =0.043) were also reported significantly higher among those women who were single (Table 4).

Anxiety symptomsSingle ()Married () value

Anxious mood9355%7645%0.013
Depressed mood8358%6142%0.003
Somatic (muscular)5461%3439%0.007
Somatic (sensory)6349%6752%0.708
Cardiovascular symptoms5450%5551%0.987
Respiratory symptoms6357%4843%0.043
Gastrointestinal symptoms6558%4843%0.023
Genitourinary symptoms8253%7447%0.227
Autonomic symptoms6147%6953%0.378
Behavior at interview5659%3941%0.021

The Chi-square statistic is significant at the 0.05 level.

4. Discussion

This study is aimed at determining the prevalence of anxiety and depressive symptoms among PCOS patients and at identifying the possible effect of sociodemographic profile on the prevalence of these symptoms.

More than one-third of the women with PCOS (40%) reported anxiety symptoms, out of which 18% had moderate while 6% had severe. It is theorized that the reason behind this is the nature of their anxiety being secondary to their condition rather than primary. The most common symptom of anxiety was tension, while the least was somatic pain. A possible explanation for the prevalence of anxiety in PCOS women is the physical manifestations of their condition, such as acne, obesity, and hirsutism which lead to negative self-image and low self-esteem [18]. Also, they might experience fear and worries regarding the future and their ability to conceive [18].

In this study, anxiety symptoms were assessed among different socioeconomic factors and were found significantly higher in single women compared to their married counterparts. Studies consistent with this suggested that PCOS symptoms such as obesity, hirsutism, and menstrual irregularities are possibly placing women under the pressure of low self-esteem, negative body image, concerns about future complications, and difficulty finding a life partner, which in turn may increase stress caused by the society regarding marital status and physical appearance [10, 19, 20]. A western study showed that singlehood was a predictor of anxiety due to stressors regarding loneliness, financial support, and social commitments; unfortunately, no local studies were found regarding the singlehood anxiety which might be influenced by our ethnicity [21]. In contrast, a study that assessed quality of life on such women found that there was no impact of menstrual cycle disturbances nor infertility on the mental well-being of the participants; such finding could be attributed to the fact that the mean age of that study is higher than ours; thus, menstruation and fertility concerns are associated mostly with younger age [22].

On further assessment of the patients’ anxiety symptoms, single women reported tension and fear as the most prevalent symptoms. Researches suggest that the possible reasons for such findings are the negative reaction from society regarding the patient’s physical appearance, android fat distribution, acne, and masculine body hair, which might eventually trigger fear, social phobia, and isolation [19, 23].

Nonemployment and low income were the other socioeconomic factors highly associated with anxiety symptoms among this study’s population. Nonemployment was pointed out by literature as a known risk factor for both anxiety and depression [24]. The state of being jobless might affect the individual negatively due to financial and economic difficulties emerging from the lack of income sources. Nonemployment is not only a stressor due to financial obligations but it also gives a sense of low self-esteem and identity issues, since employment helps the person shape their identity, be in continual social interactions, and to earn social ranks that creates the individual’s self-image [24].

Depressive symptoms were noted in 122 participants (49%). Similarly, another study that was conducted on women with PCOS to determine the risk of depression found that the prevalence of depression was 40% [25]. The high prevalence of depressive symptoms among PCOS patients could be due to several causes. Such as biological (infertility and premenstrual symptoms) or hormonal factors. Contrarily, a study which was conducted on 120 PCOS patients reported that 68.3% were nondepressed [26]. The variation in results could be due to the differences in cultural and ethnic backgrounds. Seeing that in Middle Eastern patriarchal society women are placed under a higher social pressure regarding marriage and childbearing. In this current study, mild to moderate depression scores were the most prevalent with a percentage of 30% for mild and 19% for moderate. On the other hand, a meta-analysis found that 11 studies reported a high prevalence of moderate to severe depressive symptomatology among PCOS women [27].

Fatigue and sleep disturbances were the most reported depressive symptoms in a study conducted on 103 women with PCOS, while in this current study, it was found that depressed mood and psychological anxiety were the two most prominent symptoms with a percentage of 62% [28]. Suicidal ideation was found to be the least reported depressive symptom with a percentage of 10%. On the other hand, a case-control study conducted in Sweden to assess the relationship between PCOS with psychiatric symptoms and disorders found that suicidal attempts were significantly seven times higher compared to the controls [29]. The difference between the suicidality rate in Sweden and this current study might be due to the influence of Islam on Muslim’s values and beliefs regarding the forbiddance of committing suicide [30].

On cross tabulation, none of the sociodemographic indicators showed significant results for depressive symptoms. However, PCOS participants who experienced conception delay had more depressive symptoms than others who did not experience any, showing as 30 (56%) vs. 19 (37%), respectively. This result is also shown in a study that was conducted in Italy comparing two groups of infertile subjects with two fertile groups using the Hamilton Depression Rating Scale [31]. Both of the infertile group scores were significantly higher than the control groups with an average of above the cutoff scores for mild depression [31]. Infertility caused by PCOS could trigger stress and psychological issues such as distress, social maladjustment, and loss of control [32]. For some women, having children is an important part of their female identity; thus, infertility affects their quality of life as well as their partner and family. Moreover, infertility is often associated with lower self-esteem, low social status, divorce, and job dissatisfaction [33]. It is noted that the effect of infertility on women depends on socio-cultural factors, traditions, and religious beliefs [34]. A study was done on Austrian women and Muslim immigrants in Vienna to assess the influence of socio-cultural (religious) background on health-related quality of life on PCOS women with infertility [34]. Austrian women reported that infertility is not as much of an obstacle as it is for Muslim women [34].

There were a number of limitations present in the study, one of which was the study type being cross-sectional. It limited the full evaluation of all PCOS aspects and its future drawbacks regarding patient’s psychology. Moreover, a methodology limitation was the use of questionnaires, resulting in response bias, selection bias, and the application of only screening tools that limited the full evaluation anxiety and depression, so the results were interpreted in the context of anxiety and depressive symptoms only, which was also due to the absence of a psychologist consultation. Moreover, some literature suggested that patients’ BMI and hormonal profile are a possible cause of their mental symptoms; thus, the lack of these measurements in this study was considered as a limitation. Also, the study being conducted in one center and the lack of a control group were considered limitations due to the inability to acquire a comprehensive picture regarding anxiety and mood disorders in PCOS population in Riyadh.

5. Conclusion

The overall prevalence of depressive symptoms in women with PCOS was 49%, compared to anxiety symptoms which were present among 40%. Single marital status and unemployment were predictors of anxiety among women with PCOS. Clinicians should be aware of the high risk of developing anxiety or depression syndromes among these women and screen them regularly for the presence of said symptoms. Appropriate pharmacological treatment alongside proper psychotherapeutics and psychosocial support should be included in the treatment plan.

Data Availability

Data is available from the principal investigator upon request. However, it cannot be shared online as per data sharing restrictions from the approving body.

Conflicts of Interest

We declare no conflict of interest.


We acknowledge obe/gyn clinics in the primary healthcare centre of Kashm Al-An for their assistance in reaching females with PCOS and all women who participated in this study.


  1. S. Sirmans and K. Pate, “Epidemiology, diagnosis, and management of polycystic ovary syndrome,” Clinical Epidemiology, vol. 6, p. 1, 2013. View at: Publisher Site | Google Scholar
  2. R. Nidhi, V. Padmalatha, R. Nagarathna, and R. Amritanshu, “Prevalence of polycystic ovarian syndrome in Indian adolescents,” Journal of Pediatric and Adolescent Gynecology, vol. 24, no. 4, pp. 223–227, 2011. View at: Publisher Site | Google Scholar
  3. A. Al-Ruhaily, U. Malabu, and R. Sulimani, “Hirsutism in Saudi females of reproductive age: a hospital-based study,” Annals of Saudi Medicine, vol. 28, no. 1, pp. 28–32, 2008. View at: Publisher Site | Google Scholar
  4. R. Legro, S. Arslanian, D. Ehrmann et al., “Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline,” The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 12, pp. 4565–4592, 2013. View at: Publisher Site | Google Scholar
  5. S. Karrer-Voegeli, F. Rey, M. Reymond, J. Meuwly, R. Gaillard, and F. Gomez, “Androgen dependence of hirsutism, acne, and alopecia in women,” Medicine, vol. 88, no. 1, pp. 32–45, 2009. View at: Publisher Site | Google Scholar
  6. J. Tan, Q. Wang, G. Feng, X. Li, and W. Huang, “Increased risk of psychiatric disorders in women with polycystic ovary syndrome in Southwest China,” Chinese Medical Journal, vol. 130, no. 3, pp. 262–266, 2017. View at: Publisher Site | Google Scholar
  7. H. Almis, F. Orhon, S. Bolu, and B. Almis, “Self-concept, depression, and anxiety levels of adolescents with polycystic ovary syndrome,” Journal of Pediatric and Adolescent Gynecology, vol. S1083-3188, no. 20, article 30407-1, 2020. View at: Publisher Site | Google Scholar
  8. L. Borghi, D. Leone, E. Vegni et al., “Psychological distress, anger and quality of life in polycystic ovary syndrome: associations with biochemical, phenotypical andsocio-demographic factors,” Journal of Psychosomatic Obstetrics and Gynecology, vol. 39, pp. 128–137, 2017. View at: Publisher Site | Google Scholar
  9. A. Couto Alves, B. Valcarcel, V. Mäkinen et al., “Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity,” International Journal of Obesity, vol. 41, pp. 1331–1340, 2017. View at: Publisher Site | Google Scholar
  10. G. Açmaz, E. Albayrak, B. Acmaz et al., “Level of anxiety, depression, self-esteem, social anxiety, and quality of life among the women with polycystic ovary syndrome,” Scientific World Journal, vol. 2013, pp. 1–7, 2013. View at: Publisher Site | Google Scholar
  11. Z. Behjati-Ardakani, M. Navabakhsh, and S. H. Hosseini, “Sociological study on the transformation of fertility and childbearing concept in Iran,” Journal of Reproduction & Infertility, vol. 18, no. 1, pp. 153–161, 2017. View at: Google Scholar
  12. A. Deeks, M. Gibson-Helm, and H. Teede, “Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation,” Fertility and Sterility, vol. 93, no. 7, pp. 2421–2423, 2010. View at: Publisher Site | Google Scholar
  13. M. Hamilton, “The assessment of anxiety states by rating,” The British Journal of Medical Psychology, vol. 32, no. 1, pp. 50–55, 1959. View at: Publisher Site | Google Scholar
  14. M. Hamilton, “A rating scale for depression,” Journal of Neurology, Neurosurgery, and Psychiatry, vol. 23, no. 1, pp. 56–62, 1960. View at: Publisher Site | Google Scholar
  15. A. Khalifa, Z. Bishry, A. Tantawy et al., “Psychiatric morbidity in Egyptian children with acute lymphoblastic leukemia and their care providers,” Hematology/Oncology and Stem Cell Therapy, vol. 7, no. 2, pp. 76–84, 2014. View at: Publisher Site | Google Scholar
  16. L. Fatim, Hamilton Anxiety Rating Scale, Egypt, Alanglo library, 1994.
  17. Fatim, Hamilton Checklist of Depressive Illness, Alanglo library, Egypt, 1994.
  18. M. Azizi and F. Elyasi, “Psychosomatic aspects of polycystic ovarian syndrome: a review,” Iranian Journal of Psychiatry and Behavioral Sciences, vol. 11, no. 2, pp. 21–30, 2017. View at: Publisher Site | Google Scholar
  19. F. Bazarganipour, S. Ziaei, A. Montazeri, F. Foroozanfard, A. Kazemnejad, and S. Faghihzadeh, “Body image satisfaction and self-esteem status among the patients with polycystic ovary syndrome,” Iranian Journal of Reproductive Medicine, vol. 11, no. 10, pp. 829–836, 2013. View at: Google Scholar
  20. S. Tan, S. Hahn, S. Benson et al., “Psychological implications of infertility in women with polycystic ovary syndrome,” Human Reproduction, vol. 23, no. 9, pp. 2064–2071, 2008. View at: Publisher Site | Google Scholar
  21. V. P. Ta, A. N. Gesselman, B. L. Perry, H. E. Fisher, and J. R. Garcia, “Stress of singlehood: marital status, domain-specific stress, and anxiety in a national U.S. sample,” Journal of Social and Clinical Psychology, vol. 36, no. 6, pp. 461–485, 2017. View at: Publisher Site | Google Scholar
  22. S. Hahn, O. Janssen, S. Tan et al., “Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome,” European Journal of Endocrinology, vol. 153, no. 6, pp. 853–860, 2005. View at: Publisher Site | Google Scholar
  23. J. S. Lee, “It’s not just physical: the adverse psychosocial effects of polycystic ovary syndrome in adolescents,” Women's Health, vol. 3, pp. 20–27, 2015. View at: Google Scholar
  24. M. Stankunas, R. Kalediene, S. Starkuviene, and V. Kapustinskiene, “Duration of unemployment and depression: a cross-sectional survey in Lithuania,” BMC Public Health, vol. 6, no. 1, p. 174, 2006. View at: Publisher Site | Google Scholar
  25. A. Kerchner, W. Lester, S. Stuart, and A. Dokras, “Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study,” Fertility and Sterility, vol. 91, no. 1, pp. 207–212, 2009. View at: Publisher Site | Google Scholar
  26. M. Rahiminejad, A. Moaddab, S. Rabiee, F. Esna-Ashari, S. Borzouei, and S. Hosseini, “The relationship between clinicobiochemical markers and depression in women with polycystic ovary syndrome,” Iranian Journal of Reproductive Medicine, vol. 12, no. 12, pp. 811–816, 2014. View at: Google Scholar
  27. L. G. Cooney, I. Lee, M. D. Sammel, and A. Dokras, “High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis,” Human Reproduction, vol. 32, no. 5, pp. 1075–1091, 2017. View at: Publisher Site | Google Scholar
  28. E. Hollinrake, A. Abreu, M. Maifeld, B. J. Van Voorhis, and A. Dokras, “Increased risk of depressive disorders in women with polycystic ovary syndrome,” Fertility and Sterility, vol. 87, no. 6, pp. 1369–1376, 2007. View at: Publisher Site | Google Scholar
  29. M. Mansson, J. Holte, K. Landin-Wilhelmsen, E. Dahlgren, A. Johansson, and M. Landén, “Women with polycystic ovary syndrome are often depressed or anxious—a case control study,” Psychoneuroendocrinology, vol. 33, no. 8, pp. 1132–1138, 2008. View at: Publisher Site | Google Scholar
  30. A. Shah and M. Chandia, “The relationship between suicide and Islam: a cross-national study,” Journal of Injury and Violence Research, vol. 2, no. 2, pp. 93–97, 2010. View at: Publisher Site | Google Scholar
  31. S. Fassino, A. Piero, S. Boggio, V. Piccioni, and L. Garzaro, “Anxiety, depression and anger suppression in infertile couples: a controlled study,” Human Reproduction, vol. 17, no. 11, pp. 2986–2994, 2002. View at: Publisher Site | Google Scholar
  32. S. Eggers and S. Kirchengast, “The polycystic ovary syndrome – a medical condition but also an important psychosocial problem,” Collegium Antropologicum, vol. 25, no. 2, pp. 673–685, 2001. View at: Google Scholar
  33. T. Wischmann, K. Schilling, B. Toth et al., “Sexuality, self-esteem and partnership quality in infertile women and men,” Geburtsh Frauenheilk, vol. 74, no. 8, pp. 759–763, 2014. View at: Publisher Site | Google Scholar
  34. J. Schmid, S. Kirchengast, E. Vytiska-Binstorfer, and J. Huber, “Infertility caused by PCOS health- related quality of life among Austrian and Moslem immigrant women in Austria,” Human Reproduction, vol. 19, no. 10, pp. 2251–2257, 2004. View at: Publisher Site | Google Scholar

Copyright © 2021 Wadha K. Almeshari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles